Clinical Trials Directory

Trials / Conditions / Acute Lymphoblastic Leukemia, Pediatric

Acute Lymphoblastic Leukemia, Pediatric

34 registered clinical trials studyying Acute Lymphoblastic Leukemia, Pediatric13 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Phase I Dose Finding Study of MB-CART2219.1
NCT07108868
University Hospital TuebingenPhase 1
RecruitingA Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI
NCT06559345
The First Affiliated Hospital of Zhengzhou UniversityPhase 2
RecruitingA Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI C
NCT06564493
The First Affiliated Hospital of Zhengzhou UniversityPhase 2
RecruitingMassage Impact on Sleep in Pediatric Oncology
NCT06892158
Children's Hospital of PhiladelphiaN/A
RecruitingBehavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
NCT06074666
Roswell Park Cancer InstituteN/A
RecruitingTreatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea
NCT06257394
Hyoung Jin KangPhase 2
SuspendedBrain MRF in Children, Adolescents and Young Adults With Acute Leukemia
NCT06421155
Case Comprehensive Cancer CenterN/A
RecruitingVirtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia
NCT06722638
Children's National Research InstituteN/A
RecruitingCD-19 CAR-T Cell for Pediatric ALL or Lymphoma
NCT06866873
Hong Kong Children's HospitalN/A
RecruitingDetermining the Mechanisms of Loss of CAR T Cell Persistence
NCT05809284
University College, London
UnknownParental Perception of Their Child's Emotional Quality of Life in Paediatric Oncology Before and After "Magic
NCT06107478
Centre Leon Berard
RecruitingLong Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood Acute Lymphoblastic Leukem
NCT06334835
IRCCS SYNLAB SDN
UnknownMinimal Residual Disease Quantification by Next-generation Sequencing in Pediatric B-ALL Children Patients Tre
NCT05837689
Xiaojun Xu
CompletedVaccine Immune Recovery After Leukemia
NCT05622682
Children's Hospital of Philadelphia
CompletedPhysical Exercise and Dairy Probiotics in Childhood Cancer Survivors
NCT05939791
Comenius UniversityN/A
CompletedPhase II Study of Anti-CD19 CAR-T Cells Treating Leukemia Children
NCT04325841
Beijing Boren HospitalPhase 2
RecruitingCombined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 D
NCT05029531
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyPhase 3
CompletedSafety and Efficacy of Curcumin in Children With Acute Lymphoblastic Leukemia
NCT05045443
Ain Shams UniversityPhase 2
CompletedPalbociclib in Combo w/Chemotherapy in Peds Relapsed/Refractory Acute Lymphoblastic Leukemia
NCT04996160
Tanja Andrea GruberPhase 1
CompletedEFFECT OF TREADMILL TRAINING ON BALANCE AFTER CHEMOTHERAPY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
NCT05032716
Cairo UniversityN/A
CompletedPharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia
NCT04770922
Cipherome, Inc.
CompletedHealthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivo
NCT04472286
University of Nebraska
TerminatedCAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL
NCT04049383
Medical College of WisconsinPhase 1
CompletedBiology and Benefits of Music Play and Stories for Kids/Parents During ALL Treatment
NCT04400071
Indiana UniversityN/A
UnknownThe Individualized Treatment of 6-mercaptopurine in Children With Acute Lymphoblastic Leukemia in China
NCT04228393
Wei ZhaoPhase 2 / Phase 3
Active Not RecruitingCD22-CAR T Cells in Children and Young Adults With B Cell Malignancies
NCT04088864
Stanford UniversityPhase 1
CompletedMRD Detection by NGS in Pediatric B-ALL
NCT05973032
The Children's Hospital of Zhejiang University School of Medicine
RecruitingTreatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-gener
NCT03676504
University Hospital HeidelbergPhase 1 / Phase 2
RecruitingTreatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
NCT03643276
Martin SchrappePhase 3
TerminatedInternational Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic
NCT03705507
University of BirminghamPhase 1 / Phase 2
CompletedMRD Detection by NGS in Pediatric T-ALL
NCT06525116
The Children's Hospital of Zhejiang University School of Medicine
Active Not RecruitingLow GI Diet in Children and Adolescents With ALL
NCT03157323
Columbia UniversityN/A
Active Not RecruitingTreatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
NCT03020030
Dana-Farber Cancer InstitutePhase 3
UnknownStudy of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL)
NCT03035344
Aristotle University Of Thessaloniki